首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Systemic effects of chronically administered methyl prednisolonate and methyl 17-deoxyprednisolonate
Authors:E Olejniczak  H J Lee
Institution:Center for Anti-inflammatory Research College of Pharmacy, Florida A&M University Tallahassee, Florida 32307 USA
Abstract:The systemic activities of methyl prednisolonate and methyl 17-deoxyprednisolonate (1) were studied in rats. Methyl 17-deoxyprednisolonate produced significant changes in the amount of sodium ion (decreased) and potassium ion (increased) in urine; however, methyl prednisolonate had no effect on electrolyte balance. Both methyl prednisolonate and methyl 17-deoxyprednisolonate had no effect on liver glycogen content, plasma corticosterone level and relative adrenal weight. In contrast, the parent compound prednisolone caused a significant decrease in liver glycogen content, plasma corticosterone level and relative adrenal weight.
Keywords:Steroid nomenclature: prednisolone (11β17  21-trihydroxy-1  4-pregnadiene-3  20-dione)  methyl prednisolonate (methyl 11β  17-dihydroxy-3  20-dioxo-1  4-pregnadien-21-oate)  methyl 17-deoxyprednisolonate (methyl 11β-hydroxy-3  20-dioxo-1  4-pregnadien-21-oate)  11-deoxycorticosterone (21-hydroxy-4-pregnene-3  20-dione)  budesonide (16  17-butylidenebis(oxy)-11  21-dihydroxypregna-1  4-diene-3  20-dione)
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号